Cryopreservation alters antigenicity of allografts in a porcine model of transplant vasculopathy

Transplantation Proceedings

Volumn 36, Issue 10, 2004, Pages 3288-3294

  Solanes, N ^a,d   Rigol, M ^a   Castella M ^a   Khabiri, E ^a   Ramirez J ^b   Segales J ^c   Roque M ^a   Agusti E ^a   Perez Villa F ^a   Roig, E ^a   Pomar, J L ^a   Sanz, G ^a   Heras, M ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d Inst de Malalties Cardiovasculars   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; CYCLOSPORIN A; ALLOANTIGEN; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ALLOGRAFT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGENICITY; ARTERY GRAFT; ARTICLE; AUTOTRANSPLANTATION; BLOOD VESSEL DIAMETER; CONTROLLED STUDY; CORONARY ARTERY SURGERY; CRYOPRESERVATION; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; FEMORAL ARTERY; GRAFT REJECTION; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; SWINE; T LYMPHOCYTE; VASCULAR DISEASE; ALLOTRANSPLANTATION; ANIMAL; CORONARY BLOOD VESSEL; GRANULOCYTE; IMMUNOLOGY; INTIMA; METHODOLOGY; TRANSPLANTATION; TUNICA MEDIA;

ANIMALS; CORONARY VESSELS; CRYOPRESERVATION; CYCLOSPORINE; GRANULOCYTES; IMMUNOSUPPRESSIVE AGENTS; ISOANTIGENS; MACROPHAGES; MODELS, ANIMAL; SWINE; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TUNICA INTIMA; TUNICA MEDIA;

EID: 21244465553     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.10.053     Document Type: Article

References (25)

1. Paz MA, Lupon J, Bosch X, et al: Predictors of early saphenous vein aortocoronary bypass graft occlusion. The GESIC Study Group. Ann Thorac Surg 56:1101, 1993
2. He GW: Arterial grafts for coronary artery bypass grafting: biological characteristics, functional classification, and clinical choice. Ann Thorac Surg 67:277, 1999
3. He GW: Arterial grafts for coronary surgery: vasospasm and patency rate. J Thorac Cardiovasc Surg 121:431, 2001
4. Eskew TD, Ollerenshaw JD, Philpott JM, et al: Successful small diameter arterial grafting using cryopreserved allograft arteries. ASAIO J 43:M522, 1997
5. Rigol M, Heras M, Martinez A, et al: Changes in the cooling rate and medium improve the vascular function in cryopreserved porcine femoral arteries. J Vasc Surg 31:1018, 2000
6. Carpenter JP, Tomaszewski JE: Human saphenous vein allograft bypass grafts: immune response. J Vasc Surg 27:492, 1998
7. Takamoto S, Nakajima S, Okita Y, et al: Cryopreserved femoral arterial allografts for vascular access in hemodialysis. Transplant Proc 30:3917, 1998
8. Kreitmann B, Riberi A, Zeranska M, et al: Growth potential of aortic autografts and allografts: effects of cryopreservation and immunosuppression in an experimental model. Eur J Cardiothorac Surg 11:943, 1997
9. Moriyama S, Utoh J, Sun L, et al: Clinical controversy concerning the use of cryopreserved allografts in cardiovascular surgery. Transplant Proc 32:336, 2000
10. Nataf P, Guettier C, Martinelli L, et al: Cryopreserved small-diameter arterial allografts for arterial by-pass procedures: an experimental study. J Cardiovasc Surg (Torino) 36:79, 1995
11. Mehta D, Angelini GD, Bryan AJ: Experimental models of accelerated atherosclerosis syndromes. Int J Cardiol 56:235, 1996
12. Born GVR: The aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194:927, 1962
13. Vischjager M, Van Gulik TM, Van Marle J, et al: Function of cryopreserved arterial allografts under immunosuppressive protection with cyclosporine A. J Vasc Surg 24:876, 1996
14. Mesa F, Serra JM, Herreros J: Vascular cryopreservation in microsurgery. J Reconstr Microsurg 13:245, 1997
15. Takeishi M, Hirase Y, Kojima T: Experimental study of cryopreserved allogeneic transfer of vessel: preliminary report. Microsurgery 15:55, 1994
16. Komorowska-Timek E, Zhang F, Shi DY, et al: Effect of cryopreservation on patency and histological changes of arterial isogeneic and allogeneic grafts in the rat model. Ann Plast Surg 49:404, 2002
17. Vischjager M, Van Gulik TM, De Kleine RH, et al: Experimental arterial allografting under low and therapeutic dosages of cyclosporine for immunosuppression. Transplantation 61:1138, 1996
18. Fellstrom B, Backman U, Larsson E, et al: Immunologic and nonimmunologic risk factors of chronic rejection. Transplant Proc 31:1304, 1999
19. Hayry P: Chronic rejection: an update on the mechanism. Transplant Proc 30:3993, 1998
20. Plissonnier D, Nochy D, Poncet P, et al: Sequential immunological targeting of chronic experimental arterial allograft. Transplantation 60:414, 1995
21. Schmitz-Rixen T, Megerman J, Colvin RB, et al: Immunosuppressive treatment of aortic allografts. J Vasc Surg 7:82, 1988
22. Auch-Schwelk W, Bossaller C, Gotze S, et al: Endothelial and vascular smooth muscle function after chronic treatment with cyclosporin A. J Cardiovasc Pharmacol 21:435, 1993
23. Bujan J, Bellon JM, Jurado F, et al: Assessment of cyclosporine A-induced ultrastructural changes in vascular wall using an experimental arterial autograft model. Histol Histopathol 10:567, 1995
24. Geerling RA, de Bruin RW, Scheringa M, et al: Suppression of acute rejection prevents graft arteriosclerosis after allogeneic aorta transplantation in the rat. Transplantation 58:1258, 1994
25. Richter MH, Richter H, Barten M, et al: Cyclosporin A does not enhance the development of transplant vasculopathy: experimental study in a rat cardiac transplant model. Transplant Proc 34:1479, 2002.